ImmunityBio
IBRX
#3398
Rank
HK$26.18 B
Marketcap
HK$37.58
Share price
-2.42%
Change (1 day)
39.91%
Change (1 year)

Earnings for ImmunityBio (IBRX)

Earnings in 2024 (TTM): -HK$3.55 Billion

According to ImmunityBio's latest financial reports the company's current earnings are HK$1.3 Million. In 2023 the company made an earning of -HK$3.54 Billion a decrease over its 2022 earnings that were of -HK$2.76 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ImmunityBio from 2020 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -HK$3.55 Billion0.34%
2023 -HK$3.54 Billion28.52%
2022 -HK$2.76 Billion5.61%
2021 -HK$2.61 Billion54.4%
2020 -HK$1.69 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-HK$0.98 Billion-72.45%๐Ÿ‡บ๐Ÿ‡ธ USA